These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21939488)
1. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. Numao N; Kawakami S; Sakura M; Yoshida S; Koga F; Saito K; Masuda H; Fujii Y; Yamamoto S; Yonese J; Ishikawa Y; Fukui I; Kihara K BJU Int; 2012 Mar; 109(5):665-71. PubMed ID: 21939488 [TBL] [Abstract][Full Text] [Related]
2. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091 [TBL] [Abstract][Full Text] [Related]
3. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406 [TBL] [Abstract][Full Text] [Related]
4. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633 [TBL] [Abstract][Full Text] [Related]
5. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related]
8. Prostate biopsy: who, how and when. An update. Djavan B; Milani S; Remzi M Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [TBL] [Abstract][Full Text] [Related]
9. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Hara R; Jo Y; Fujii T; Kondo N; Yokoyoma T; Miyaji Y; Nagai A Urology; 2008 Feb; 71(2):191-5. PubMed ID: 18308081 [TBL] [Abstract][Full Text] [Related]
10. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. Hossack T; Patel MI; Huo A; Brenner P; Yuen C; Spernat D; Mathews J; Haynes AM; Sutherland R; del Prado W; Stricker P J Urol; 2012 Sep; 188(3):781-5. PubMed ID: 22819419 [TBL] [Abstract][Full Text] [Related]
11. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy. De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cancers detected at only a sextant or alternative location. Ochiai A; Troncoso P; Babaian RJ BJU Int; 2008 Apr; 101(7):837-40. PubMed ID: 18070187 [TBL] [Abstract][Full Text] [Related]
14. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412 [TBL] [Abstract][Full Text] [Related]
15. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study. Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201 [TBL] [Abstract][Full Text] [Related]
17. Complications of transrectal versus transperineal prostate biopsy. Miller J; Perumalla C; Heap G ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517 [TBL] [Abstract][Full Text] [Related]
19. Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores? Scattoni V; Roscigno M; Raber M; Dehò F; Maga T; Zanoni M; Riva M; Sangalli M; Nava L; Mazzoccoli B; Freschi M; Guazzoni G; Rigatti P; Montorsi F J Urol; 2008 Apr; 179(4):1327-31; discussion 1331. PubMed ID: 18289580 [TBL] [Abstract][Full Text] [Related]
20. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Scattoni V; Raber M; Abdollah F; Roscigno M; Dehò F; Angiolilli D; Maccagnano C; Gallina A; Capitanio U; Freschi M; Doglioni C; Rigatti P; Montorsi F Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]